Showing items 1–100
High throughput BH3 profiling: a rapid and scalable technology to BH3 profile on low…
Grant US-11867688-B2
United States of America
Methods of BH3 profiling
Grant US-11867687-B2
United States of America
Dynamic BH3 profiling
Grant US-11815508-B2
United States of America
Treatment of acute myeloid leukemia (AML) with venetoclax failure
Grant US-11793802-B2
United States of America
Peptidyl inhibitors of calcineurin-NFAT interaction
Grant US-11576946-B2
United States of America
Treatment of a disease of the gastrointestinal tract with an immunosuppressant
Grant US-11523772-B2
United States of America
Treatment regimen for cancers that are insensitive to BCL-2 inhibitors using the MCL-1…
Grant US-11497756-B2
United States of America
Non-ionic and thermoresponsive diblock copolypeptide hydrogels for delivery of molecules…
Grant US-11298424-B2
United States of America
Alvocidib prodrugs and their use as protein kinase inhibitors
Grant US-11279694-B2
United States of America
BH3 peptides and methods of use thereof
Grant US-11225511-B2
United States of America
Cell penetrating peptides and methods of making and using thereof
Grant US-11225506-B2
United States of America
Methods of determining cellular chemosensitivity
Grant US-11215608-B2
United States of America
Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy
Grant US-11168310-B2
United States of America
Selective delivery molecules and methods of use
Grant US-11052160-B2
United States of America
CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer
Grant US-11034710-B2
United States of America
Aptamer therapeutics useful in the treatment of complement-related disorders
Grant US-10947544-B2
United States of America
Production of arginine-rich proteins from wastewater and use as a fertilizer
Grant US-10934224-B2
United States of America
COMBINATION THERAPIES USING CYCLOSPORINE AND AROMATIC CATIONIC PEPTIDES
Application US-20200376074-A1
United States of America
Combination therapies for treatment of cancer
Grant US-10835537-B2
United States of America
Cell penetrating peptides and methods of making and using thereof
Grant US-10815276-B2
United States of America
High throughput BH3 profiling: a rapid and scalable technology to BH3 profile on low…
Grant US-10761086-B2
United States of America
Methods of BH3 profiling
Grant US-10739333-B2
United States of America
Combination therapies for treatment of cancer
Grant US-10682356-B2
United States of America
Predicting response to alvocidib by mitochondrial profiling
Grant US-10624880-B2
United States of America
Cell penetrating peptides and methods of making and using thereof
Grant US-10626147-B2
United States of America
Tumor radiosensitization with monomethyl auristatin E (MMAE) and derivatives thereof
Grant US-10596259-B2
United States of America
Combination therapies for treatment of cancer
Grant US-10568887-B2
United States of America
Alvocidib prodrugs having increased bioavailability
Grant US-10562925-B2
United States of America
Peptidyl calcineurin inhibitors
Grant US-10456443-B2
United States of America
Composition with high antimicrobial activity and low toxicity
Grant US-10448634-B2
United States of America
Profiling peptides and methods for sensitivity profiling
Grant US-10422788-B2
United States of America
Dynamic BH3 profiling
Grant US-10393733-B2
United States of America
Personalized protease assay to measure protease activity in neoplasms
Grant US-10385380-B2
United States of America
Predicting response to alvocidib by mitochondrial profiling
Grant US-10357488-B2
United States of America
Profiling peptides and methods for sensitivity profiling
Grant US-10267787-B2
United States of America
Peptides whose uptake by cells is controllable
Grant US-10259845-B2
United States of America
Alvocidib prodrugs having increased bioavailability
Grant US-10259835-B2
United States of America
Selective delivery molecules and methods of use
Grant US-10226539-B2
United States of America
Oligopeptidic compounds and uses thereof
Grant US-10213483-B2
United States of America
Profiling peptides and methods for sensitivity profiling
Grant US-10132797-B2
United States of America
Cyclic-GluR6 analogs, methods of treatment and use
Grant US-10046024-B2
United States of America
Pretargeted activatable cell penetrating peptide with intracellularly releasable prodrug
Grant US-10029017-B2
United States of America
COMPOSITION FOR SKIN PENETRATION, CONTAINING CATIONIC MOLECULE TRANSPORTER AND ANIONIC…
Application EP-3162367-A4
European Patent Office
RTEF-1 variants and the use thereof for inhibition of angiogenesis
Grant US-9937269-B2
United States of America
BH3 peptides and methods of use thereof
Grant US-9902759-B2
United States of America
BH3 peptides and method of use thereof
Grant US-9856303-B2
United States of America
Peptides whose uptake in cells is controllable
Grant US-9808532-B2
United States of America
Selective delivery molecules and methods of use
Grant US-9782498-B2
United States of America
Activatable cell penetrating peptides with quenched fluorophores
Grant US-9695251-B2
United States of America
Peptides whose uptake in cells is controllable
Grant US-9682151-B2
United States of America
Oligopeptidic compounds and uses thereof
Grant US-9676822-B2
United States of America
RTEF-1 variants and uses thereof
Grant US-9650426-B2
United States of America
Generation of functional and durable endothelial cells from human amniotic fluid-derived…
Grant US-9637723-B2
United States of America
Aptamer therapeutics useful in the treatment of complement-related disorders
Grant US-9617546-B2
United States of America
Methods of determining cellular chemosensitivity
Grant US-9540674-B2
United States of America
Dual-action, unnatural proline-rich peptides as antibiotic agents and methods thereof
Grant US-9533975-B2
United States of America
RTEF-1 variants and the use thereof for inhibition of angiogenesis
Grant US-9512423-B2
United States of America
Skin permeating and cell entering (SPACE) peptides and methods of use thereof
Grant US-9441014-B2
United States of America
Cyclic-GluR6 analogs, methods of treatment and use
Grant US-9403876-B2
United States of America
Oligopeptide compounds and uses thereof
Grant US-9353156-B2
United States of America
Methods of forming a micronized peptide coated stent
Grant US-9084671-B2
United States of America
Peptides whose uptake by cells is controllable
Grant US-9072792-B2
United States of America
Aptamer therapeutics useful in the treatment of complement-related disorders
Grant US-8946184-B2
United States of America
Oligopeptidic compounds and uses thereof
Grant US-8871724-B2
United States of America
Stabilized aptamers to platelet derived growth factor and their use as oncology…
Grant US-8853376-B2
United States of America
Skin permeating and cell entering (SPACE) peptides and methods of use thereof
Grant US-8791062-B2
United States of America
RTEF-1 variants and uses thereof
Grant US-8785385-B2
United States of America
Oligopeptide compounds and uses thereof
Grant US-8754042-B2
United States of America
RTEF-1 variants and the use thereof for inhibition of angiogenesis
Grant US-8748379-B2
United States of America
Compositions and methods for enhancing drug delivery across and into ocular tissues
Grant US-8729010-B2
United States of America
Synthetic diblock copolypeptide hydrogels for use in the central nervous system
Grant US-8691204-B2
United States of America
Cloned transmembrane receptor for 24-hydroxylated vitamin D compounds and uses thereof
Grant US-8663937-B2
United States of America
Cloned transmembrane receptor for 24-hydroxylated vitamin D compounds and uses thereof
Grant US-8663934-B2
United States of America
Cloned transmembrane receptor for 24-hydroxylated vitamin D compounds and uses thereof
Grant US-8663986-B2
United States of America
Cloned transmembrane receptor for 24-hydroxylated vitamin D compounds and uses thereof
Grant US-8658854-B2
United States of America
Peptides whose uptake by cells is controllable
Grant US-8642561-B2
United States of America
Compositions and methods for enhancing drug delivery across and into epithelial tissues
Grant US-8623833-B2
United States of America
ψεrack peptide composition and method for protection against tissue damage due to ischemia
Grant US-8592363-B2
United States of America
Skin permeating and cell entering (SPACE) peptides and methods of use thereof
Grant US-8518871-B2
United States of America
Micronized peptide coated stent
Grant US-8506617-B1
United States of America
Aptamer therapeutics useful in the treatment of complement-related disorders
Grant US-8436164-B2
United States of America
Compositions and methods for enhancing drug delivery across and into ocular tissues
Grant US-8278264-B2
United States of America
Aptamer therapeutics useful in the treatment of complement-related disorders
Grant US-8236773-B2
United States of America
Peptides whose uptake by cells is controllable
Grant US-8110554-B2
United States of America
Materials and methods for the generation of fully 2′-modified nucleic acid transcripts
Grant US-8105813-B2
United States of America
Materials and methods for the generation of transcripts comprising modified nucleotides
Grant US-8101385-B2
United States of America
Implantable medical devices incorporating plasma polymerized film layers and charged…
Grant US-8067023-B2
United States of America
Recombinant melusin fusion protein as pharmacological agent in the treatment of heart…
Application EP-2386570-A1
European Patent Office
Aptamers to von Willebrand factor and their use as thrombotic disease therapeutics
Grant US-7998940-B2
United States of America
ψεRACK peptide composition and method for protection against tissue damage due to ischemia
Grant US-7985726-B2
United States of America
High affinity nucleic acid ligands of complement system proteins
Grant US-7964572-B2
United States of America
treatment of cell damage caused by ischemia or stroke by administering to a cell or a…
Grant US-7915219-B2
United States of America
Polycationic peptides for cardiovascular therapy
Grant US-7901703-B2
United States of America
Polycationic peptide coatings and methods of coating implantable medical devices
Grant US-7875286-B2
United States of America
CYCLIC-GLUR6 ANALOGS, METHODS OF TREATMENT AND USE
Application WO-2010135277-A3
World Intellectual Property Organisation (WIPO)
BH3 peptides and method of use thereof
Grant US-7868133-B2
United States of America
Dendrimers as molecular translocators
Grant US-7862807-B2
United States of America
Peptides for activation and inhibition of δPKC
Grant US-7851586-B2
United States of America
CYCLIC-GLUR6 ANALOGS, METHODS OF TREATMENT AND USE
Application WO-2010135277-A2
World Intellectual Property Organisation (WIPO)
Showing items 1–100